Cabotegravir is an antiretroviral medication used for treating HIV infections. As with any medication, there may be impurities present in the drug substance or the drug product. The impurities may be related to the synthetic process used to manufacture the drug, degradation products, or other contaminants. It is important to monitor and control the levels of impurities in Cabotegravir to ensure the drug's safety and efficacy. A thorough understanding of the impurities and their potential effects on patients is essential for regulatory compliance and patient safety.
